These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 8545839)
21. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity. Ruh MF; Zacharewski T; Connor K; Howell J; Chen I; Safe S Biochem Pharmacol; 1995 Oct; 50(9):1485-93. PubMed ID: 7503800 [TBL] [Abstract][Full Text] [Related]
22. Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum. Moore M; Mustain M; Daniel K; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P Toxicol Appl Pharmacol; 1997 Jan; 142(1):160-8. PubMed ID: 9007045 [TBL] [Abstract][Full Text] [Related]
23. In vivo estrogenic and antiestrogenic activity of phenolphthalein and derivative compounds. Nieto A; García C; López de Haro MS Biochem Int; 1990; 21(2):305-11. PubMed ID: 2403370 [TBL] [Abstract][Full Text] [Related]
24. Antiestrogenic effect of paradichlorobenzene in immature mice and rats. Takahashi O; Oishi S; Yoneyama M; Ogata A; Kamimura H Arch Toxicol; 2007 Jul; 81(7):505-17. PubMed ID: 17593412 [TBL] [Abstract][Full Text] [Related]
25. CDRI-85/287: studies on competition to estrogen binding sites in the immature rat uterus. Sreenivasulu S; Dwivedi A; Singh MM; Setty BS; Kamboj VP Indian J Exp Biol; 1992 Dec; 30(12):1115-7. PubMed ID: 1294475 [TBL] [Abstract][Full Text] [Related]
26. Effects of daily anti-estrogen treatment on uterine growth and progesterone receptor concentrations in adult rat uterus. Janssens JP; Billiet G; Bonte J; De Loecker W Anticancer Res; 1984; 4(3):157-62. PubMed ID: 6465854 [TBL] [Abstract][Full Text] [Related]
27. Estrogen supplementation modulates effects of the endocrine disrupting pollutant PCB126 in rat bone and uterus: diverging effects in ovariectomized and intact animals. Lind PM; Eriksen EF; Lind L; Orberg J; Sahlin L Toxicology; 2004 Jul; 199(2-3):129-36. PubMed ID: 15147787 [TBL] [Abstract][Full Text] [Related]
28. Failure of chloro-S-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro. Connor K; Howell J; Chen I; Liu H; Berhane K; Sciarretta C; Safe S; Zacharewski T Fundam Appl Toxicol; 1996 Mar; 30(1):93-101. PubMed ID: 8812239 [TBL] [Abstract][Full Text] [Related]
29. 3,3'4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells. Ramamoorthy K; Gupta MS; Sun G; McDougal A; Safe SH Carcinogenesis; 1999 Jan; 20(1):115-23. PubMed ID: 9934858 [TBL] [Abstract][Full Text] [Related]
30. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor. Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859 [TBL] [Abstract][Full Text] [Related]
31. Relationship between aryl hydrocarbon receptor-affinity and the induction of EROD activity by 2,3,7,8-tetrachlorinated phenothiazine and derivatives. Fried KW; Bazzi R; Levy Lopez W; Corsten C; Schramm KW; Bell DR; Rozman KK Toxicol Appl Pharmacol; 2007 Oct; 224(2):147-55. PubMed ID: 17761204 [TBL] [Abstract][Full Text] [Related]
32. Antitumor activities and estrogen receptor interactions of the metabolites of the antiestrogens C1628 and U23,469 in the 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor system. Rorke EA; Katzenellenbogen BS Cancer Res; 1981 Apr; 41(4):1257-62. PubMed ID: 6783294 [No Abstract] [Full Text] [Related]
33. 5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal human progesterone receptor agonists. Zhi L; Tegley CM; Kallel EA; Marschke KB; Mais DE; Gottardis MM; Jones TK J Med Chem; 1998 Jan; 41(3):291-302. PubMed ID: 9464360 [TBL] [Abstract][Full Text] [Related]
34. Estrogen to antiestrogen with a single methylene group resulting in an unusual steroidal selective estrogen receptor modulator. Zhang JX; Labaree DC; Mor G; Hochberg RB J Clin Endocrinol Metab; 2004 Jul; 89(7):3527-35. PubMed ID: 15240642 [TBL] [Abstract][Full Text] [Related]
35. Regulation of rat uterine steroid receptors by nomegestrol acetate, a new 19-nor-progesterone derivative. Botella J; Duc I; Delansorne R; Paris J; Lahlou B J Pharmacol Exp Ther; 1989 Feb; 248(2):758-61. PubMed ID: 2918478 [TBL] [Abstract][Full Text] [Related]
36. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile. Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G Menopause; 2005; 12(5):589-600. PubMed ID: 16145313 [TBL] [Abstract][Full Text] [Related]
37. A comparative study of antiestrogen action: temporal patterns of antagonism of estrogen stimulated uterine growth and effects on estrogen receptor levels. Ferguson ER; Katzenellenbogen BS Endocrinology; 1977 May; 100(5):1242-51. PubMed ID: 849721 [TBL] [Abstract][Full Text] [Related]
38. Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator. McDougal A; Wormke M; Calvin J; Safe S Cancer Res; 2001 May; 61(10):3902-7. PubMed ID: 11358803 [TBL] [Abstract][Full Text] [Related]
39. Homologs of idoxifene: variation of estrogen receptor binding and calmodulin antagonism with chain length. Hardcastle IR; Rowlands MG; Grimshaw RM; Houghton J; Jarman M J Med Chem; 1996 Feb; 39(4):999-1004. PubMed ID: 8632423 [TBL] [Abstract][Full Text] [Related]
40. 2,5-Diphenylfuran-based pure antiestrogens with selectivity for the estrogen receptor alpha. Zimmermann J; Liebl R; von Angerer E J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):57-66. PubMed ID: 15862950 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]